Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination-Reference-Cited by-同舟云学术

Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination

Published:2024-01 Issue:1 Volume:24 Page:e1-e3
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Stankov Metodi V,Hoffmann Markus,Gutierrez Jauregui Rodrigo,Cossmann Anne,Morillas Ramos Gema,Graalmann Theresa,Winter Emily Jo,Friedrichsen Michaela,Ravens Inga,Ilievska Tamara,Ristenpart Jasmin,Schimrock Anja,Willenzon Stefanie,Ahrenstorf Gerrit,Witte Torsten,Förster Reinhold,Kempf Amy,Pöhlmann Stefan,Hammerschmidt Swantje I,Dopfer-Jablonka Alexandra,Behrens Georg M N

Funder

Niedersächsisches Ministerium für Wissenschaft und Kultur

DFG

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference10 articles.

1. Safety and immunogenicity of XBB.1.5-containing mRNA Vaccines;Chalkias;medRxiv,2023

2. Neutralization, effector function and immune imprinting of omicron variants;Addetia;Nature,2023

3. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution;Cao;Nature,2023

4. Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination;Barros-Martins;Nat Med,2021

5. BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19;Behrens;Nat Commun,2022

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment;Vaccine;2024-11

2. Humoral Immunity after mRNA Omicron JN.1 Vaccination;2024-09-06

3. Repeated Omicron infection dampens immune imprinting from previous vaccination and induces broad neutralizing antibodies against Omicron sub-variants;Journal of Infection;2024-08

4. Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster;Cell Reports Medicine;2024-08

5. Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives;Journal of the Formosan Medical Association;2024-08